{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:37:09Z","timestamp":1792103829969,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ajg.2022.05.002","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T09:21:25Z","timestamp":1654593685000},"page":"11-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of hepatosteatosis in patients with chronic hepatitis B virus infection"],"prefix":"10.1016","volume":"24","author":[{"given":"Merve","family":"Sefa Sayar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2022.05.002_b0005","series-title":"Global hepatitis report, 2017","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.ajg.2022.05.002_b0010","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment and of chronic hepatitisB: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ajg.2022.05.002_bib151","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatotology"},{"issue":"2","key":"10.1016\/j.ajg.2022.05.002_b0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/hep.30857","article-title":"Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B","volume":"71","author":"Choi","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2022.05.002_b0025","first-page":"111","article-title":"The prevalence of non-alcoholic fatty liver disease in healthy young persons","volume":"3","author":"Okur","year":"2016","journal-title":"North Clin Istanb"},{"key":"10.1016\/j.ajg.2022.05.002_b0030","first-page":"41","article-title":"Epidemiologic features of nonalcoholic fatty liver in urban community of Elaz\u0131\u011f","volume":"5","author":"\u00c7elebi","year":"2006","journal-title":"Akademik Gastroenteroloji Dergisi"},{"issue":"1124","key":"10.1016\/j.ajg.2022.05.002_b0035","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/postgradmedj-2018-136316","article-title":"Diagnosis and management of non-alcoholic fatty liver disease","volume":"95","author":"Jennison","year":"2019","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ajg.2022.05.002_b0040","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ajg.2022.05.002_b0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12072-018-9903-9","article-title":"Fatty liver checkmates hepatitis B virus","volume":"12","author":"Ramakrishna","year":"2018","journal-title":"Hepatol Int"},{"issue":"36","key":"10.1016\/j.ajg.2022.05.002_b0050","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.3748\/wjg.v22.i36.8161","article-title":"Impact of hepatitis B virus infection on hepatic metabolic signaling pathway","volume":"22","author":"Shi","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajg.2022.05.002_b0055","doi-asserted-by":"crossref","first-page":"12989","DOI":"10.3748\/wjg.v21.i46.12989","article-title":"Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with Viral hepatitis-associated steatosis","volume":"21","author":"Haga","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ajg.2022.05.002_b0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4274\/Vhd.53825","article-title":"Ultrasonographic Assessment of the prevalence of hepatic steatosis in inactive hepatitis B carriers","volume":"19","author":"Inci","year":"2013","journal-title":"Viral Hepat J"},{"issue":"1","key":"10.1016\/j.ajg.2022.05.002_b0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5152\/tjg.2015.150348","article-title":"Impact of fatty liver on hepatitis B virus replication and virologic response to tenofovir and entecavir","volume":"27","author":"Ceylan","year":"2016","journal-title":"Turk J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ajg.2022.05.002_b0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4274\/vhd.0001","article-title":"Percutaneous liver needle biopsy methods can be safe and effective in patients with viral hepatitis","volume":"23","author":"Karacaer","year":"2017","journal-title":"Viral Hepat J"},{"key":"10.1016\/j.ajg.2022.05.002_b0075","first-page":"185","article-title":"APRI is not a useful predictor of fibrosis for patients with chronic hepatitis B","volume":"9","author":"Mahtab","year":"2009","journal-title":"Hepat Mon"},{"issue":"2","key":"10.1016\/j.ajg.2022.05.002_b0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ajg.2013.05.002","article-title":"Role of fibroscan and APRI in detection of liver fibrosis: A systematic review and meta-analysis.","volume":"14","author":"Abd El Rihim","year":"2013","journal-title":"Arab J Gastroenterol"},{"issue":"4","key":"10.1016\/j.ajg.2022.05.002_b0085","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","article-title":"AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis","volume":"7","author":"Loaeza-del-Castillo","year":"2008","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.ajg.2022.05.002_b0090","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1478-3231.2006.01287.x","article-title":"Non-invasive models for predicting histology in patients with chronic hepatitis B","volume":"26","author":"Wai","year":"2006","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.ajg.2022.05.002_b0095","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10620-012-2343-9","article-title":"Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without","volume":"58","author":"Chu","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.ajg.2022.05.002_b0100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cgh.2011.12.019","article-title":"Incidence and determinants of spontaneous seroclearance of hepatitis B e antigen and DNA in patients with chronic hepatitis B","volume":"10","author":"Yang","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ajg.2022.05.002_b0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jhepr.2019.02.002","article-title":"Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load","volume":"1","author":"Peleg","year":"2019","journal-title":"JHEP Rep"},{"issue":"7","key":"10.1016\/j.ajg.2022.05.002_b0110","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/jvh.13095","article-title":"Fibrosis evolution in chronic hepatitis B e antigen-negative patients across a 10-year interval","volume":"26","author":"Mak","year":"2019","journal-title":"J Viral Hepat"},{"issue":"4","key":"10.1016\/j.ajg.2022.05.002_b0115","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.ajg.2022.05.002_b0120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cld.579","article-title":"Natural history of nonalcoholic steatohepatitis\/nonalcoholic fatty liver disease-hepatocellular carcinoma: Magnitude of the problem from a hepatology clinic perspective","volume":"8","author":"D\u2019Avola","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ajg.2022.05.002_b0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/liv.12074","article-title":"Treatment of HBV related cirrhosis","volume":"33","author":"van B\u00f6mmel","year":"2013","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.ajg.2022.05.002_b0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ajg.2022.05.002_b0135","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstr\u00f6m","year":"2017","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.ajg.2022.05.002_b0140","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2022.05.002_b0145","doi-asserted-by":"crossref","first-page":"e38346","DOI":"10.5812\/hepatmon.38346","article-title":"Fibroscan compared to FIB-4, APRI, and AST\/ALT ratio for assessment of liver fibrosis in Saudi patients with nonalcoholic fatty liver disease","volume":"16","author":"Fallatah","year":"2016","journal-title":"Hepat Mon"},{"key":"10.1016\/j.ajg.2022.05.002_b0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ajg.2011.327","article-title":"Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma","volume":"107","author":"Kawamura","year":"2012","journal-title":"Am J Gastroenterol"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197922000351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197922000351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:45:43Z","timestamp":1761659143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197922000351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1687197922000351"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2022.05.002","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of hepatosteatosis in patients with chronic hepatitis B virus infection","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2022.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}